@alk_fusion

Patient centric research with a focus on collaboration and disease management.

 Everywhere!!
Joined April 2019
  • Tweets67
  • Following172
  • Followers550
3Media
ALKFusion retweeted
IASLC
@IASLC15 Jun 2021
Download Now: The @IASLC Language Guide. Established to instill best practices regarding commonly used phrases related to patient-related data & discussion during presentations at conferences and within submitted abstracts. iaslc.org/IASLCLanguageGuide #WordsMatter #JoinTheMovement

IASLC Language Guide | IASLC

The following Language Guide has been developed by members of the IASLC to provide guidelines on best practices with common phrases used during presentations at ...

iaslc.org
1
16
9
40
Clinical trials are an important consideration in your lung cancer treatment path, but finding the right one can be overwhelming. Why should you join one? What are the risks? Check out our Clinical Trials FAQs to learn more: bit.ly/30PiolT
1
3
9
#livingwithlungcancer #LCSM
This Post is from a suspended account. Learn more
3
Check out the latest volume of the ALK Reporter from @alk_fusion #lcsm #ALK alkfusion.org/wp-content/upl…
1
4
1
15
Fact Friday | About 2/3 of never smokers diagnosed with #lungcancer are women. Act now to make sure your representative’s are prioritizing this women’s healthcare issue. #lcsm >> bit.ly/2lVcGNf
1
5
3
14
Research shows Alectinib works after Crizotinib; ALK resistance mutations can be analyzed from a blood sample. Tumour biopsy may not be necessary. Thank you Dr. Alice Shaw & team! #ResearchMatters #lcsm #LCAM #ALK #lungcancer #HotoffthePress jto.org/article/S1556-0864(1…

ALK Mutation Status Before and After Alectinib Treatment in Locally Advanced or Metastatic ALK-Po...

The effectiveness of ALK receptor tyrosine kinase (ALK) inhibitors can be limited by the development of ALK resistance mutations. This exploratory analysis assessed the efficacy of alectinib in...

jto.org
1
3
12
We’re proud to announce that we have reached 50 Cosponsors on the Women and Lung Cancer Research and Preventive Services Act of 2019! This momentum is critical to the future of #WomeninLungCancer. See if your representatives have signed on. If not, act. >> bit.ly/2NubI5Q
2
12
8
30
.@JenniferCKing @GO2Foundation The majority of both patients and oncologists agree that there is a stigma associated with lung cancer #LCSM #WCLC19 #NoStigma
4
10
Colleen and Shelly getting ready for some poster action!! Come see us at: P2.02-01! We will have a hot off the press ALK Reporter for you! #WCLC19 @IASLC @shelly_et @ZieglerColleen
5
7
A lot of options... Butt we still need more!!! #WCLC2019 @IASLC #lcsm
This Post is from a suspended account. Learn more
3
1
4
Great talk and important take home messages by @ChristianRolfo on liquid biopsy for lung cancer patients. #lcsm #oncoalert #WCLC19 @drgandara @IASLC
15
1
31
Replying to @BrendonStilesMD @EGFRResisters @IASLC
I don't think you should limit that to young nonsmokers. Many ALK and EGFR patients have some smoking history. And others are really old. EVERYONE should be tested. @alk_fusion #lcsm
2
3
10
Dr. Shaw, breaking down ALK options in Barcelona. #WCLC2019 #lcsm
3
2
28
Partnering with patients to disrupt the research paradigm, accelerate research & ensure the research is patient focused! Visit our collaborative poster. Thank you @JFreemanDaily! #WCLC19 #DISRUPTERS #LCSM @EGFRResisters @ALKLungCancer @ros1cancer @Exon20Group @alk_fusion
21
2
35
Colleen and Shelly at world lung with @TakedaOncology #WCLC19
1
10
Such an important study that will help prospectively validate the approach of tailoring ALK inhibitors based upon ALK resistance mutations. #WCLC19 #LCSM @alk_fusion
Laura Greco@lgreco_ny8 Sep 2019
Super important new study for all ALK patients. Upon progression, talk about your doctor re enrolling! @alk_fusion #WCLC19 #lcsm
4
19
ALKFusion retweeted
IASLC
@IASLC26 Aug 2019
On Thursday, Aug. 29, we will host a webinar titled, "Women and Lung Cancer: Screening, Treatment and Beyond." This program will discuss the global impact of #lungcancer on women and the changing landscape. #LCSM Registration: bit.ly/2LNcFql
19
2
28
ALKFusion retweeted
IASLC
@IASLC15 Jul 2019
On July 22, we will host a webinar designed specifically for Patient Research Advocates. Join @BairdAM and our very own Patient Advocacy Manager @KAdvocate_LCAM for this special event! #LCSM Register: bit.ly/2YqDm6U
12
1
18
ALCMI & @DanaFarber launch a nationwide study to better understand why treatment resistance develops in ALK-Positive lung cancer patients. @geoff_oxnard #SPACEWALK #ALCMI #BeatLungCancer #LCSM alcmi.net/media/press-releas…
7
1
13
Load more